Apart from melanoma, the links between β2M alteration and acquired resistance have been reported in lung cancer (42), gastrointestinal adenocarcinoma (43), and colorectal cancer with a microsatellite instability–high (MSI-H) phenotype (44). This evidence concerns the gene B2M and melanoma.